Scribd Logo
Upload

Welcome to Scribd!

  • 45 views

    Leading Global Blockbuster Drugs

    Uploaded by

    Latif Jamadar
    The document lists the top 25 global blockbuster drugs by sales in 2007. Lipitor, for cholesterol, was the top selling drug with $13.7 billion in sales. Plavix, for thrombotic events, was second with $8.1 billion in sales and a 28% growth rate. The third highest selling drug was Advair/Seretide for asthma with $7 billion in sales and 14% growth. In total, the top 25 drugs generated $120.7 billion in sales in 2007, a 7% increase from the previous year.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content

    You might also like

    Leading Global Blockbuster Drugs

    Uploaded by

    Latif Jamadar
    45 views1 page
    The document lists the top 25 global blockbuster drugs by sales in 2007. Lipitor, for cholesterol, was the top selling drug with $13.7 billion in sales. Plavix, for thrombotic events, was second with $8.1 billion in sales and a 28% growth rate. The third highest selling drug was Advair/Seretide for asthma with $7 billion in sales and 14% growth. In total, the top 25 drugs generated $120.7 billion in sales in 2007, a 7% increase from the previous year.

    Original Description:

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Available Formats

    DOCX, PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Report this Document
    The document lists the top 25 global blockbuster drugs by sales in 2007. Lipitor, for cholesterol, was the top selling drug with $13.7 billion in sales. Plavix, for thrombotic events, was second with $8.1 billion in sales and a 28% growth rate. The third highest selling drug was Advair/Seretide for asthma with $7 billion in sales and 14% growth. In total, the top 25 drugs generated $120.7 billion in sales in 2007, a 7% increase from the previous year.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    45 views1 page

    Leading Global Blockbuster Drugs

    Uploaded by

    Latif Jamadar
    The document lists the top 25 global blockbuster drugs by sales in 2007. Lipitor, for cholesterol, was the top selling drug with $13.7 billion in sales. Plavix, for thrombotic events, was second with $8.1 billion in sales and a 28% growth rate. The third highest selling drug was Advair/Seretide for asthma with $7 billion in sales and 14% growth. In total, the top 25 drugs generated $120.7 billion in sales in 2007, a 7% increase from the previous year.

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Download as DOCX, PDF, TXT or read online from Scribd
    Flag for inappropriate content
    Download as docx, pdf, or txt
    of 1

    Leading Global Blockbuster Drugs - 2007

    Drug/ Company Disease Sales $ %


    billions Growth

    1. Lipitor (Pfizer/ Astellas Pharma) Cholesterol $13.7 <1%>

    2. Plavix ( Bristol-Myers Squibb/Sanofi-Aventis) Thrombotic Events $8.1 +28%

    3. Advair/Seretide (GlaxoSmithKline) Asthma $7.0 +14%

    4. Enbrel (Amgen/Wyeth/Takeda) Rheumatoid Arthritis $5.5 +22%

    5. Remicade (Johnson & Johnson, Schering-Plough, Rheumatoid Arthritis $5.3 +18%


    Mitsubishi Tanabe)

    6. Nexium (AstraZeneca) Gastrointestinal $5.2 +1%


    Disorders

    7. Rituxan(Roche-Genentech-Chugai/Biogen Idec Cancer $5.2 +14%

    8. Diovan ( Novartis) Hypertension $5.0 +19%

    9. Zyprexa (Eli Lilly) Schizophrenia/ Anxiety $4.8 +9%

    10. Risperdal (Johnson & Johnson) Schizophrenia $4.7 +12%

    11. Actos (Takeda/Lilly) Diabetes (type 2) $4.3 +14%

    12. Singulair (Merck) Asthma $4.3 +19%

    13. Protonix/Pantozol (Nycomed, Wyeth) Gastrointestinal $4.2 +5%


    Disorders

    14. Seroquel (AstraZeneca/ Astellas) Schizophrenia $4.2 +18%

    15. Herceptin (Roche - Genentech - Chugai) Cancer $4.0 +24%

    16. Prevacid (Takeda/ Abbott Labs) Gastrointestinal $4.0 <7%>


    Disorders

    17. Effexor (Wyeth) Depression $4.0 +2%

    18. Aranesp (Amgen) Anemia $3.6 <12%>

    19.Lovenox (Sanofi-Aventis) Deep-vein Thrombosis $3.6 +7%

    20. Atacand/Biopress (candesartan) Hypertension $3.5 +11%

    21. Avastin ( Roche-Genentech-Chugai) Cancer $3.4 +39%

    22. Cozaar (Merck) Hypertension $3.4 +6%

    23. Copaxone (Teva Pharmaceuticals/Sanofi-Aventis) Multiple Schlerosis $3.3 +16%

    24. Aricept (Esai/Pfizer) Alzheimer's disease) $3.3 +14%

    25. AcipHex (Esai/Johnson & Johnson) Gastrointestinal $3.1 +3%


    Disorders

    TOTAL $120.7 +7%

    You might also like